ADIL
Adial Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.74
+0.01 (+0.37%)
Rating:B-
Company Profile
CEO
Cary John Claiborne
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.72
Prev. Close
$2.73
Day Low
$2.69
Day High
$2.75
52W Low
$1.31
52W High
$19.00
Market Cap
$0.00B
Volume
0.01M